Dupixent sales (annual)
Total net sales revenue generated by Dupixent (dupilumab).
Unit billion EUR Industry Pharmaceuticals
Records
1
Regions
1
Period
2030
Sources
1
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Dupixent sales (annual)
Global, 2030
25 billion EUR
Source: Sanofi · CC BY 4.0 · statorigin.org
Every record
All records
1 record · 1 region · 2030
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded | Sanofi | 30 Jul 2026 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Dupixent sales (annual). Retrieved from https://statorigin.org/indicators/dupixent-sales-annual